Filing Details

Accession Number:
0001652252-16-000106
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-13 18:02:49
Reporting Period:
2016-09-10
Filing Date:
2016-09-13
Accepted Time:
2016-09-13 18:02:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
12208 Bio Rad Laboratories Inc BIO, BIOB Laboratory Analytical Instruments (3826) 941381833
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1621222 Shannon Hall C/O Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules CA 94547
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Bio-Rad A Common Stock Acquisiton 2016-09-10 240 $0.00 667 No 4 M Direct
Bio-Rad A Common Stock Acquisiton 2016-09-11 840 $0.00 1,507 No 4 M Direct
Bio-Rad A Common Stock Disposition 2016-09-12 414 $155.02 1,093 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Bio-Rad A Common Stock Restricted Stock Units Disposition 2016-09-10 240 $0.00 240 $0.00
Bio-Rad A Common Stock Restricted Stock Units Disposition 2016-09-11 240 $0.00 240 $0.00
Bio-Rad A Common Stock Restricted Stock Units Disposition 2016-09-11 600 $0.00 600 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
720 No 4 M Direct
480 No 4 M Direct
2,400 No 4 M Direct
Footnotes
  1. Shares of Class A common stock acquired on the vesting of restricted stock units.
  2. Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.0162 to $155.0174, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
  5. The restricted stock units vest in five equal annual installments beginning September 10, 2015.
  6. The restricted stock units vest in five equal annual installments beginning September 11, 2014.
  7. The restricted stock units vest in five equal annual installments beginning September 11, 2016.